Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF SEPTEMBER 06, 2009 FBO #2843
AWARD

A -- RECOVERY - ACTNOW "Early Therapeutics Development with Phase II Emphasis"

Notice Date
9/4/2009
 
Notice Type
Award Notice
 
NAICS
541711 — Research and Development in Biotechnology
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Blvd., EPS Suite 600, Rockville, Maryland, 20852
 
ZIP Code
20852
 
Solicitation Number
HHSN261200622005C-M8
 
Archive Date
9/16/2009
 
Point of Contact
Michael P. Marino, Phone: 3014353801, Richard L Hartmann, Phone: (301) 496-8620
 
E-Mail Address
marinomic@mail.nih.gov, Richard.Hartmann@nih.gov
(marinomic@mail.nih.gov, Richard.Hartmann@nih.gov)
 
Small Business Set-Aside
N/A
 
Award Number
HHSN261200622005C-08
 
Award Date
8/31/2009
 
Awardee
Mayo Foundation, 200 First Street Southwest, Rochester, Minnesota 55905, United States
 
Award Amount
$499,997
 
Line Number
Modification_Eight
 
Description
This action modifies an existing contract to provide funding for ACTNOW Clinical Trial numbered 8288. The purpose of these contracts is to conduct Phase 2 and early clinical trials of NCI-sponsored agents, evaluate biologic effects of these agents on their molecular targets, evaluate other relevant biologic effects and determine clinically relevant outcomes/correlates. Major emphasis is on Phase 2 studies, pilot protocols that explore promising combination therapies, and high priority studies that are pivotal for drug development and require rapid initiation, completion, and data reporting. The principal activity funded under this program is early therapeutic research. Rationale for using other than a fixed price: These contracts reimburse the contractor on the basis of patient accrual. The number of patients accrued cannot be predicted with enough accuracy to justify a fixed price type contract, however, the Contractor is paid a fixed price for each patient accrued. Although the contracts have a fixed price cost per patient, most of the contracts include cost reimbursement provisions for non-patient care costs. Uncertanties involved in contract performance do not permit costs to be estimated with sufficient accuracy to use any type of fixed price contract. As such, a cost reimbursement type action is appropriate. DUNS: 006471700
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/Awards/HHSN261200622005C-08.html)
 
Record
SN01942505-W 20090906/090905002205-ce787529847f155f1305e4c6a1d42cc6 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.